Cardiology Update

MAY 7, 2024

The impact of chest compression (CC) pause duration on survival outcomes in pediatric in-hospital cardiac arrests remains unclear, despite the American Heart Association’s recommendation to limit pauses to less than 10 seconds for children without solid evidence. Original article: Lauridsen KG et al.

Cardiac Arrest 52

Cardiac Arrest Pediatrics Hospital Circulation 52

American College of Cardiology

AUGUST 7, 2024

Does hospital median cardiopulmonary resuscitation (CPR) duration in patients without return of circulation (ROC) predict survival among hospitalized children?

Cardiac Arrest 49

Cardiac Arrest Hospital Pediatrics Outcomes 49

HeartRhythm

OCTOBER 7, 2024

Arrhythmias can lead to cardiac arrest (CA) and heart failure. When intractable, heart transplant (HTX) can become the only viable treatment. This rare, high-risk cohort has not been reported as a distinct group.

Heart Transplant 40

Heart Transplant Transplant Arrhythmia Cardiac Arrest 40

Circulation

NOVEMBER 11, 2024

We collected demographic, pre-procedural, procedural, and outcome-related variables. The most common MAE was arrhythmia, representing 46% of MAE, followed by cardiac arrest and bleeding each 20%. Conclusion:Cardiac catheterization is a safe procedure in pediatric patients with cardiomyopathy, with an overall MAE rate of 1.6%.

Cardiomyopathy 40

Cardiomyopathy Pediatrics Heart Transplant Heart Failure 40

Stroke Journal

JANUARY 30, 2025

It can affect the functional outcome, increase risk of major adverse events, prolong LOS and increase the use of rehabilitation therapies (RT). Introduction:Pediatric heart transplant (PHT) recipient survival has improved. Yet, neurologic morbidity related to heart failure and its treatment persist.

Heart Transplant 40

Heart Transplant Transplant Pediatrics Stroke 40

Cardiometabolic Health Congress

JULY 17, 2024

Join us as we examine the landmark approvals that are revolutionizing patient outcomes. Praluent (alirocumab) (Approved: 03/11/2024) Extended to pediatric patients aged 8+ with heterozygous familial hypercholesterolemia (HeFH).

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Defibrillator 59

Dr. Smith's ECG Blog

NOVEMBER 24, 2017

However, none of the formulas have proven to be definitively better than another and none are well correlated with outcomes or events! None is considered definitive due to the paucity of data (and conflicting data) relating QTc to outcomes. We compare this rule to the 4 common formulas for correcting the QT. Some other points: 1.

Bradycardia 52

Bradycardia Article Atrial Fibrillation Chest Pain 52